Refining the CHA2DS2VASc risk stratification scheme: shall we drop the sex category criterion?

Hiroyuki Yoshimura; Rui Providência; Chris Finan; Amand F. Schmidt; Professor Gregory Lip

doi:10.1093/europace/euae280

Abstract

1 min read

Removing Sc from the CHA2DS2VASc score does not affect its ability to discriminate thromboembolic events in the population with AF. The use of CHA2DS2VA may simplify initial decision-making for thromboprophylaxis.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2024

Time-trends of sex differences in stroke risk in atrial fibrillation: Are female patients still at higher risk today? A nationwide cohort study

Peter Brønnum Nielsen, R F Broendum, A K Noehr, Thure Filskov Overvad, Professor Gregory Lip

Article2020

The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation

Tatjana Potpara, Professor Gregory Lip, Carina Blomström‐Lundqvist, Giuseppe Boriani, Isabelle C. Van Gelder, Hein Heidbüchel, Gerhard Hindricks, Alan John Camm

Letter2021

Should we make the risk stratification process more complex in patients with atrial fibrillation?

José Miguel Rivera‐Caravaca, Peter Brønnum Nielsen, Professor Gregory Lip

Article2017

Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial

María Asunción Esteve‐Pastor, José Miguel Rivera‐Caravaca, Alena Shantsila, Vanessa Roldán, Professor Gregory Lip, Francisco Marı́n

Article2017

Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

Amaya García-Fernández, Vanessa Roldán, José Miguel Rivera‐Caravaca, Diana Hernández‐Romero, Mariano Valdés, Vicente Vicente, Professor Gregory Lip, Francisco Marı́n